Literature DB >> 8882079

Accuracy of mortality data for interstitial lung diseases in New Mexico, USA.

D B Coultas1, M P Hughes.   

Abstract

BACKGROUND: The sensitivity and accuracy of death certificates and mortality data as sources of population based data on the occurrence of interstitial lung diseases has received limited attention. To determine the usefulness of these data sources, death certificates and mortality data from patients in New Mexico were examined.
METHODS: Patients with an interstitial lung disease were identified from a population based registry. For subjects who had died, diagnostic information from their death certificates and from mortality data was compared with the clinical diagnoses made before death.
RESULTS: Of 385 patients with a clinical diagnosis of an interstitial lung disease, 134 died between October 1988 and August 1994. Death certificates were obtained for 96% of these patients. An interstitial lung disease was listed somewhere on the death certificate for only 46% of the patients, and as an immediate cause of death for only 15%. For the patients with an interstitial lung disease listed somewhere on the death certificate the overall concordance between the diagnoses before death and those on the death certificate was 76%. Mortality data for the State of New Mexico showed a diagnosis of interstitial lung disease to be the assigned cause of death for only 22% of the patients. The overall agreement between the diagnoses made before death and those of the state mortality data was only 21%.
CONCLUSIONS: These results suggest that death certificates and state mortality data are neither sensitive nor accurate for describing the occurrence of interstitial lung diseases. This finding may partly explain the apparently low mortality rates from idiopathic pulmonary fibrosis in the USA compared with other countries.

Entities:  

Mesh:

Year:  1996        PMID: 8882079      PMCID: PMC472495          DOI: 10.1136/thx.51.7.717

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  5 in total

1.  NHLBI Workshop summary. Current concepts in idiopathic pulmonary fibrosis: a road map for the future.

Authors:  R M Cherniack; R G Crystal; A R Kalica
Journal:  Am Rev Respir Dis       Date:  1991-03

2.  Mortality rates from cryptogenic fibrosing alveolitis in seven countries.

Authors:  R Hubbard; I Johnston; D B Coultas; J Britton
Journal:  Thorax       Date:  1996-07       Impact factor: 9.139

3.  The epidemiology of interstitial lung diseases.

Authors:  D B Coultas; R E Zumwalt; W C Black; R E Sobonya
Journal:  Am J Respir Crit Care Med       Date:  1994-10       Impact factor: 21.405

4.  Rising mortality from cryptogenic fibrosing alveolitis.

Authors:  I Johnston; J Britton; W Kinnear; R Logan
Journal:  BMJ       Date:  1990-11-03

Review 5.  Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment.

Authors:  R J Panos; R L Mortenson; S A Niccoli; T E King
Journal:  Am J Med       Date:  1990-04       Impact factor: 4.965

  5 in total
  11 in total

1.  Ill-defined and multiple causes on death certificates--a study of misclassification in mortality statistics.

Authors:  M D'Amico; E Agozzino; A Biagino; A Simonetti; P Marinelli
Journal:  Eur J Epidemiol       Date:  1999-02       Impact factor: 8.082

2.  Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease.

Authors:  D B Sprunger; A L Olson; T J Huie; E R Fernandez-Perez; A Fischer; J J Solomon; K K Brown; J J Swigris
Journal:  Eur Respir J       Date:  2011-07-07       Impact factor: 16.671

3.  Epidemiology of organising pneumonia in Iceland.

Authors:  G Gudmundsson; O Sveinsson; H J Isaksson; S Jonsson; H Frodadottir; T Aspelund
Journal:  Thorax       Date:  2006-06-29       Impact factor: 9.139

4.  Evaluation of death certificate-based surveillance for traumatic brain injury--Oklahoma 2002.

Authors:  Sara Russell Rodriguez; Sue Mallonee; Pam Archer; Jeffery Gofton
Journal:  Public Health Rep       Date:  2006 May-Jun       Impact factor: 2.792

5.  Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts.

Authors:  D W Mapel; W C Hunt; R Utton; K B Baumgartner; J M Samet; D B Coultas
Journal:  Thorax       Date:  1998-06       Impact factor: 9.139

6.  Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy.

Authors:  Mardge H Cohen; Audrey L French; Lorie Benning; Andrea Kovacs; Kathryn Anastos; Mary Young; Howard Minkoff; Nancy A Hessol
Journal:  Am J Med       Date:  2002-08-01       Impact factor: 4.965

7.  Seasonal variation: mortality from pulmonary fibrosis is greatest in the winter.

Authors:  Amy L Olson; Jeffrey J Swigris; Ganesh Raghu; Kevin K Brown
Journal:  Chest       Date:  2008-08-08       Impact factor: 9.410

Review 8.  Pharmacogenetics and interstitial lung disease.

Authors:  Justin M Oldham; Imre Noth; Fernando J Martinez
Journal:  Curr Opin Pulm Med       Date:  2016-09       Impact factor: 3.155

Review 9.  The epidemiology of interstitial lung disease and its association with lung cancer.

Authors:  G Raghu; F Nyberg; G Morgan
Journal:  Br J Cancer       Date:  2004-08       Impact factor: 7.640

Review 10.  Epidemiology of idiopathic pulmonary fibrosis.

Authors:  Brett Ley; Harold R Collard
Journal:  Clin Epidemiol       Date:  2013-11-25       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.